Global Acute Myeloid Leukemia Treatment Market Opportunities, Historical Analysis and Potential Growth till 2023
Global Acute Myeloid Leukemia Treatment Market Information; by Disease Type (Myeloblastic, Promyeloctic, Myelomonocytic, Monocytic, Erythroleukemia, Megakaryocytic); by Treatment (Chemotherapy (Induction, Post Remission), Hematopoietic Stem Cell Transplantation) - Forecast to 2023
Market Highlights
Acute myeloid leukemia
(AML) is a cancer of the myeloid blood cells, causing extreme and rapid growth
of abnormal white blood cells of the bone marrow. The rapid buildup of abnormal
white blood cells causes interference in the production of normal blood cells.
AML has a propensity to increase towards age. Replacement of normal bone marrow
with cancer cells causes a drop in blood constituents such as red blood cells,
platelets, white blood cells etc. which causes symptoms such as fatigue,
breathlessness, easy bruising and bleeding, and increased risk of infection.
Considering all these
factors the market for acute
myeloid leukemia treatment market is expected to reach $ 1.2 billion by the end of 2023, this market is
projected to growing at a CAGR of Approx 5.3 % during 2017-2023.
The market driving factors
for acute myeloid leukemia (AML) are rise in risk factors such as exposures to
carcinogens such as ionizing radiation, chemicals etc. Presence of other blood
disorders and genetics is also involved for the higher risk of AML. Other
market drivers are increasing number of cancer hospitals, greater awareness,
good reimbursement scenario etc. The market constraints are poor cure rates of
the present drugs, serious side effects of the drugs etc.
Avail
a Free Sample@ https://www.marketresearchfuture.com/sample_request/3223
Segments
The global acute myeloid leukemia treatment market
is segmented on the basis of disease type. Based on the disease type, the
market has been segmented as myeloblastic, promyeloctic, myelomonocytic,
monocytic, erythroleukemia and megakaryocytic. Based on the treatment, the
market has been segmented as chemotherapy, and hematopoietic stem cell
transplantation. Chemotherapy is further sub-segmented into induction and post
remission.
Intended Audience
- Global acute myeloid leukemia treatment
solutions providers.
- Research and development (R&D) companies
- Market research and consulting service
providers
- Academic institutes and universities
Research Methodology
Regional Analysis
US accounts for the maximum market share due to
favorable reimbursement scenario and greater expenditure on healthcare. Europe
is the second largest market due to large disposable income and presence of
large hospitals. Asia pacific region will be the fastest region because of
large unmet needs which will be led by China and India. The Middle East and
Africa market will be led by the gulf nations particularly Saudi Arabia and
UAE. The poor regions of Africa is expected to be a laggard due to poor
economic and political conditions.
The report for Global Acute myeloid leukemia
treatment Market by Market Research Future comprises of extensive primary
research along with the detail analysis of qualitative as well as quantitative
aspects by various industry experts, key opinion leaders to gain a deeper
insight of the market and industry performance. The report gives a clear
picture of current market scenario which includes past and estimated future
market size with respect to value and volume, technological advancement, macro
economical and governing factors in the market. The report provides detail
information about and strategies used by top key players in the industry. The
report also gives a broad study of the different market segments and regions.
Access Report Details @ https://www.marketresearchfuture.com/reports/acute-myeloid-leukemia-treatment-market-3223
The report for Global market by Market
Research Future comprises of extensive primary research along with the detailed
analysis of qualitative as well as quantitative aspects by various industry
experts, key opinion leaders to gain a deeper insight of the market and
industry performance. The report gives a clear picture of the current market
scenario which includes past and estimated future market size with respect to
value and volume, technological advancement, macro economical and governing
factors in the market. The report provides detail information about and
strategies used by top key players in the industry. The report also gives a
broad study of the different market segments and regions.
Key Players
Key players profiled in the report are Johnson & Johnson, Pfizer
Inc., Celgene Corporation, Ambit Biosciences Corporation, Cyclacel
Pharmaceuticals Inc. Novartis AG and Sanofi, Bristol Myers Squibb and others.
TOC:
1.
Report Prologue
2. Market
Introduction
2.1
Definition
2.2 Scope of the
Study
2.2.1
Research Objective
2.2.2
Assumptions
2.2.3
Limitations
3. Research
Methodology
3.1 Introduction
3.2 Primary
Research
3.3 Secondary research
3.4 Market Size
Estimation
TOC…Continued
Ask
Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/3223
About Market Research Future:
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the optimum
quality market research and intelligence services to our clients. Our market
research studies by Components, Application, Logistics and market players for
global, regional, and country level market segments, enable our clients to see
more, know more, and do more, which help to answer all their most important
questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact Us:
Market
Research Future
Phone: +1 646 845 9312
Comments
Post a Comment